Article 14 Jan 2026 FDA Is Open To The Idea Of Possible Regulatory Flexibility For Cell And Gene Therapies On A Case-by-Case Basis…Where Appropriate United States Healthcare
Article 20 Feb 2025 What To Expect When You Are Expecting…A Government Shutdown United States Healthcare
Article 19 Dec 2024 FDA Issues "Cliffs Notes"-style Guidance On Cell And Gene Therapy; What CMC Questions Did They Answer? (Part 2) United States Healthcare
Article 09 Nov 2023 Lots Of FDA Guidance, But Few Drug Manufacturing "Remote Interactive Evaluations" (We Would Call Them "Virtual Inspections") United States Healthcare
Article 08 Nov 2023 Welcome To SRP-RMT – Standardization Comes To Regenerative Medicine Therapies? United States Healthcare